Cargando…
Cannabidiol improves survival and behavioural co‐morbidities of Dravet syndrome in mice
BACKGROUND AND PURPOSE: Dravet syndrome is a severe, genetic form of paediatric epilepsy associated with premature mortality and co‐morbidities such as anxiety, depression, autism, motor dysfunction and memory deficits. Cannabidiol is an approved anticonvulsive drug in the United States and Europe f...
Autores principales: | Patra, Pabitra Hriday, Serafeimidou‐Pouliou, Eleni, Bazelot, Michael, Whalley, Benjamin Jason, Williams, Claire Michelle, McNeish, Alister James |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7236080/ https://www.ncbi.nlm.nih.gov/pubmed/32321192 http://dx.doi.org/10.1111/bph.15003 |
Ejemplares similares
-
Cannabidiol reduces seizures and associated behavioral comorbidities in a range of animal seizure and epilepsy models
por: Patra, Pabitra Hriday, et al.
Publicado: (2018) -
Cannabidiol for epilepsy (Lennox-Gastaut syndrome, Dravet syndrome)
Publicado: (2020) -
Channelopathy of Dravet Syndrome and Potential Neuroprotective Effects of Cannabidiol
por: Xu, Changqing, et al.
Publicado: (2021) -
A new mechanism for cannabidiol in regulating the one‐carbon cycle and methionine levels in Dictyostelium and in mammalian epilepsy models
por: Perry, Christopher J., et al.
Publicado: (2020) -
Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome
por: Devinsky, Orrin, et al.
Publicado: (2018)